REVIVA PHARMACEUTICALS HOLDINGS INC. - COMMON STO
1.6900
15-5月-24 15:39:05
15 分の遅延
株式
-0.1350
-7.40%
本日の幅
1.6000 - 1.8100
ISIN
N/A
ソース
NASDAQ
-
15 5 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Reviva Reports First Quarter 2024 Financial Results and Recent Business Highlights
14 5 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
13 5 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
09 5 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Reviva Announces FDA Alignment on Brilaroxazine Clinical Trials for NDA in Schizophrenia
15 4 2024 08:30:00 提供 Nasdaq GlobeNewswire
-
Reviva Reports Full Year 2023 Financial Results and Recent Business Highlights
15 4 2024 08:05:00 提供 Nasdaq GlobeNewswire
-
28 3 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
26 3 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Reviva to Present at the UBS Virtual CNS Day
11 3 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Reviva to Present at the 36th Annual ROTH Conference
07 3 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Reviva Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference
20 2 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
06 2 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
25 1 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Reviva Provides Corporate and Program Updates and Highlights Key Upcoming Milestones
04 1 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Reviva to Participate in the Zacks Small-Cap Research Life Sciences Investor Forum
11 12 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
30 11 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
20 11 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Reviva Announces $30 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
16 11 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Reviva Reports Third Quarter 2023 Financial Results and Recent Business Highlights
14 11 2023 16:01:00 提供 Nasdaq GlobeNewswire
-
30 10 2023 07:30:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >